Experienced in Relapsed Refractory Multiple Myeloma (RRMM)

Dr. Adam D. Cohen

Geriatrics
Northwell Health
1000 Northern Boulevard, Suite 340, 
Great Neck, NY 
On Staff At
Offers Telehealth

Experienced in Relapsed Refractory Multiple Myeloma (RRMM)
Northwell Health
1000 Northern Boulevard, Suite 340, 
Great Neck, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adam Cohen is a Geriatrics provider in Great Neck, New York. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Prolidase Deficiency, Alzheimer's Disease, Urinary Tract Infection (UTI), Relapsed Refractory Multiple Myeloma (RRMM), and Endoscopy.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Boston University School Of Medicine
Residency
Bronx Municipal Hospital Center
Specialties
Geriatrics
Licenses
Geriatric Medicine in NY
Fellowships
Long Island Jewish Medical Center
Hospital Affiliations
Long Island Jewish Medical Center
North Shore University Hospital
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

1000 Northern Boulevard, Suite 340, Great Neck, NY 11021
Call: 516-775-9090

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the Efficacy and Safety of Two Doses of the Antibody Drug Conjugate GSK2857916 in Participants With Multiple Myeloma Who Had 3 or More Prior Lines of Treatment, Are Refractory to a Proteasome Inhibitor and an Immunomodulatory Agent and Have Failed an Anti-CD38 Antibody (DREAMM 2)
A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the Efficacy and Safety of Two Doses of the Antibody Drug Conjugate GSK2857916 in Participants With Multiple Myeloma Who Had 3 or More Prior Lines of Treatment, Are Refractory to a Proteasome Inhibitor and an Immunomodulatory Agent and Have Failed an Anti-CD38 Antibody (DREAMM 2)
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin Frozen Liquid, Belantamab Mafodotin Lyophilized Powder
Study Phase: Phase 2
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2025
Intervention Type: Drug, Procedure
Study Drugs: Lenalidomide, Bortezomib, Dexamethasone
Study Phase: Phase 3
View 2 Less Clinical Trials

110 Total Publications

Outcomes of relapse after teclistamab therapy in multiple myeloma.
Outcomes of relapse after teclistamab therapy in multiple myeloma.
Journal: Blood cancer journal
Published: August 14, 2025
View All 110 Publications
Similar Doctors
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Raymond D. Pastore
Hematology Oncology | Palliative Medicine | Geriatrics
Advanced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Raymond D. Pastore
Hematology Oncology | Palliative Medicine | Geriatrics

Weill Medical College Of Cornell

425 E 61st St, Suite 8, 
New York, NY 
 (12.0 miles away)
212-746-0923
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Raymond Pastore is a Hematologist Oncology specialist and a Palliative Medicine provider in New York, New York. Dr. Pastore is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Polycythemia Vera, Blood Clots, Childhood Iron Deficiency Anemia, Factor 11 Deficiency, and Bone Marrow Aspiration.

Experienced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Ani Cioffo
Geriatrics
Experienced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Ani Cioffo
Geriatrics

HMH - John Theurer Cancer Center - Hackensack

92 2nd Street, 
Hackensack, NJ 
 (17.8 miles away)
551-996-5900
Languages Spoken:
English
See accepted insurances

Ani Cioffo is a Geriatrics provider in Hackensack, New Jersey. Dr. Cioffo is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top area of expertise is Relapsed Refractory Multiple Myeloma (RRMM).

Experienced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Sung W. Sun
Geriatrics | Internal Medicine
Experienced in Relapsed Refractory Multiple Myeloma (RRMM)
Dr. Sung W. Sun
Geriatrics | Internal Medicine

Memorial Medical Consultation Group

1275 York Ave, 
New York, NY 
 (11.8 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sung Sun is a primary care provider, practicing in Geriatrics and Internal Medicine in New York, New York. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Muscle Invasive Bladder Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Lung Cancer.

VIEW MORE RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cohen's expertise for a condition
ConditionClose
      • Advanced
      • Alzheimer's Disease
        Dr. Cohen is
        Advanced
        . Learn about Alzheimer's Disease.
        See more Alzheimer's Disease experts
      • Prolidase Deficiency
        Dr. Cohen is
        Advanced
        . Learn about Prolidase Deficiency.
        See more Prolidase Deficiency experts
      • Experienced
      • Anemia
        Dr. Cohen is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      • Atrial Fibrillation
        Dr. Cohen is
        Experienced
        . Learn about Atrial Fibrillation.
        See more Atrial Fibrillation experts
      • Classical Hodgkin Lymphoma
        Dr. Cohen is
        Experienced
        . Learn about Classical Hodgkin Lymphoma.
        See more Classical Hodgkin Lymphoma experts
      • Dementia
        Dr. Cohen is
        Experienced
        . Learn about Dementia.
        See more Dementia experts
      • Endoscopy
        Dr. Cohen is
        Experienced
        . Learn about Endoscopy.
        See more Endoscopy experts
      • Familial Hypertension
        Dr. Cohen is
        Experienced
        . Learn about Familial Hypertension.
        See more Familial Hypertension experts
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.